Contact Lens Wettability
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00349063 |
Recruitment Status
:
Completed
First Posted
: July 6, 2006
Last Update Posted
: July 19, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Ametropia | Device: soft contact lens Drug: Soft contact lens multipurpose disinfection regimen | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 55 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | The Impact of Short Term Wearing Time on In Vivo and Ex Vivo Wettability |
Study Start Date : | July 2005 |

- To investigate the impact of wearing time and contact lens care solutions on in
- vivo and ex vivo wettability of currently marketed contact lenses
- To determine if there is a correlation between in vivo wettability, ex vivo
- wettability and in-eye comfort. To determine if comfort and wettability vary
- between symptomatic and asymptomatic lens wearers.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 16 Years and older (Child, Adult, Senior) |
Sexes Eligible for Study: | All |
Inclusion Criteria:
- Has had an oculo-visual examination in the last two years.
- Is at least 18 years old and has full legal capacity to volunteer or is at least 16 years old, has a parent or guardian’s permission to participate in the study and has read the Information and Consent Letter for adolescents.
4. Has read and understood the Information Consent Letter (Appendix II). 5. Is willing and able to follow participant instructions for product usage and meet the protocol-specified schedule of follow-up visits.
6. Has a refractive error that is correctable with the prescription of the available study lenses.
7. Has a refractive error that is correctable to at least 20/25 distance visual acuity with contact lenses in each eye.
8. Has acceptable fit with the study lenses. 9. Has clear corneas, and ocular clinical findings are considered “normal”.
Exclusion Criteria:
- Has any systemic disease that may affect ocular health.
- Is using any systemic or topical medications that may affect ocular health.
- Has any ocular pathology or severe insufficiency of lacrimal secretion (dry eyes) that may affect the wearing of contact lenses.
- Has any clinically significant lid or conjunctival abnormalities, meibomian gland dysfunction, neovascularization, corneal scars or corneal opacities.
- Has limbal injection, bulbar injection or corneal staining that, in the investigator's opinion, is clinically significant.
- Has pinguecula and/or pterygium that, in the investigator's judgement, makes contact lens wear inadvisable.
- Has refractive astigmatism of more than 0.75 D.
- Has corneal distortion resulting from rigid lens wear.
- Is aphakic.
- Has undergone corneal refractive surgery.
- Is participating in any other type of clinical or research study.
- Is pregnant or lactating.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00349063
Canada, Ontario | |
Centre for Contact Lens Research, University of Waterloo | |
Waterloo, Ontario, Canada, N2L 3G1 |
Principal Investigator: | Craig Woods, PhD | University of Waterloo | |
Principal Investigator: | Desmond Fonn, MOptom | University of Waterloo |
ClinicalTrials.gov Identifier: | NCT00349063 History of Changes |
Other Study ID Numbers: |
P/217/05/L |
First Posted: | July 6, 2006 Key Record Dates |
Last Update Posted: | July 19, 2006 |
Last Verified: | July 2006 |
Additional relevant MeSH terms:
Refractive Errors Eye Diseases |